CHS Inc Preferred (CHSCN) Financials

CHSCN

Trailing 12 months to May 31, 2026

Revenue $37.4B +3.8% YoY

Net Income $577.5M +12.6% YoY

Free Cash Flow $932.9M +388.9% YoY

Operating Cash Flow $1.5B +208.1% YoY

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended May 31, 2026 Reported Jul 8, 2026 Currency USD FYE August

Newest figures come from the 10-Q for Q3 FY2026, filed Jul 8, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CHSCN SEC filings page.

CHS Inc Preferred (CHSCN) reported $37.4B in revenue over the twelve months to May 31, 2026, up 3.8% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CHSCN FY2025 2026-08-30

The business is becoming a thinner-margin, cash-hungrier operator despite restrained balance-sheet leverage.

Operating cash conversion weakened sharply: operating cash flow fell from $3.3B in FY2023 to $635.8M in FY2025, a steeper deterioration than the sales decline alone would imply. With $728.6M of capital expenditures still recorded, free cash flow reached -$92.8M; accounting profit did not translate into discretionary cash in the latest year.

Revenue contracted from $45.6B in FY2023 to $35.5B in FY2025, making scale a headwind rather than a source of operating absorption. In FY2025, gross margin was 3.2% and operating margin just 0.3%; the spread leaves little profit cushion when volume falls.

The financing posture is not being propped up by rising leverage: debt-to-equity was 0.2x and the current ratio was 1.5x in FY2025, even as free cash flow turned negative. Liabilities fell from $8.5B in FY2023 to $7.8B in FY2025, indicating that the latest cash pressure is more tied to earnings and reinvestment than debt expansion.

Financial Health Signals

Financial health score not available

CHS Inc Preferred does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial

4/8

CHS Inc Preferred passes 4 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed

1.06x

For every $1 of reported earnings, CHS Inc Preferred generates $1.06 in operating cash flow ($635.8M OCF vs $597.9M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage At Risk

0.62x

CHS Inc Preferred earns $0.62 in operating income for every $1 of interest expense ($90.8M vs $146.1M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$11.6B

YoY+18.6%

QoQ+38.6%

5Y CAGR+1.2%

10Y CAGR+4.0%

CHS Inc Preferred generated $11.6B in revenue in Q3 2026. This represents an increase of 18.6% from the same quarter a year earlier. Against the prior quarter it is up 38.6%.

EBITDA

$273.7M

YoY+18.8%

QoQ+495.7%

5Y CAGR+0.9%

10Y CAGR+0.3%

CHS Inc Preferred's EBITDA was $273.7M in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 18.8% from the same quarter a year earlier. Against the prior quarter it is up 495.7%.

Net Income

$267.4M

YoY+15.2%

QoQ+281.8%

5Y CAGR-0.5%

10Y CAGR+3.5%

CHS Inc Preferred reported $267.4M in net income in Q3 2026. This represents an increase of 15.2% from the same quarter a year earlier. Against the prior quarter it is up 281.8%.

EPS (Diluted)

Not reported for Q3 2026.

Cash & Balance Sheet

Free Cash Flow

$984.7M

YoY+89.1%

QoQ+246.1%

5Y CAGR+18.1%

CHS Inc Preferred generated $984.7M in free cash flow in Q3 2026, representing cash available after capex. This represents an increase of 89.1% from the same quarter a year earlier. Against the prior quarter it is up 246.1%.

Cash & Debt

$497.6M

YoY+53.7%

QoQ+100.3%

5Y CAGR+10.6%

10Y CAGR+3.7%

CHS Inc Preferred held $497.6M in cash against $2.0B in long-term debt as of Q3 2026.

Shares Outstanding

CHS Inc Preferred had 0 shares outstanding in Q3 2026.

Dividends Per Share

Not reported for Q3 2026.

Margins & Returns

Gross Margin

3.5%

YoY+0.2pp

QoQ+3.2pp

5Y change+0.7pp

10Y change-0.5pp

CHS Inc Preferred's gross margin was 3.5% in Q3 2026, indicating the percentage of revenue retained after direct costs. This is up 0.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 3.2 percentage points.

Operating Margin

0.9%

YoY+0.2pp

QoQ+3.8pp

5Y change-0.2pp

10Y change-1.0pp

CHS Inc Preferred's operating margin was 0.9% in Q3 2026, reflecting core business profitability. This is up 0.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 3.8 percentage points.

Net Margin

2.3%

YoY-0.1pp

QoQ+4.1pp

5Y change-0.2pp

10Y change-0.1pp

CHS Inc Preferred's net profit margin was 2.3% in Q3 2026, showing the share of revenue converted to profit. This is down 0.1 percentage points from the same quarter a year earlier. Against the prior quarter it is up 4.1 percentage points.

Return on Equity

2.4%

YoY+0.2pp

QoQ+3.7pp

5Y change-0.7pp

10Y change0.0pp

CHS Inc Preferred's ROE was 2.4% in Q3 2026, measuring profit generated per dollar of shareholder equity. This is up 0.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 3.7 percentage points.

Capital Allocation

Capital Expenditures

$123.3M

YoY-29.9%

QoQ+17.5%

5Y CAGR+10.7%

10Y CAGR-0.5%

CHS Inc Preferred invested $123.3M in capex in Q3 2026, funding long-term assets and infrastructure. This represents a decrease of 29.9% from the same quarter a year earlier. Against the prior quarter it is up 17.5%.

R&D Spending

Not reported for Q3 2026.

Share Buybacks

Not reported for Q3 2026.

CHSCN Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CHSCN quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$37.4B	$35.5B-9.7%	$39.3B-13.9%	$45.6B-4.6%	$47.8B+24.3%	$38.4B+35.4%	$28.4B-11.0%	$31.9B-2.4%	$32.7B+2.0%	$32.0B+5.5%	$30.4B-12.2%	$34.6B-18.9%	$42.7B-4.1%	$44.5B+9.6%	$40.6B+10.0%	$36.9B
Cost of Revenue	$36.3B	$34.3B-8.5%	$37.5B-13.2%	$43.2B-5.4%	$45.7B+21.8%	$37.5B+36.7%	$27.4B-10.1%	$30.5B-3.4%	$31.6B+1.4%	$31.1B+6.0%	$29.4B-11.2%	$33.1B-19.3%	$41.0B-4.0%	$42.7B+10.7%	$38.6B+8.7%	$35.5B
Gross Profit	$1.2B	$1.1B-35.1%	$1.8B-26.3%	$2.4B+11.7%	$2.1B+123.6%	$951.4M-3.1%	$981.8M-29.1%	$1.4B+26.8%	$1.1B+22.2%	$893.9M-7.7%	$968.7M-35.0%	$1.5B-9.8%	$1.7B-7.1%	$1.8B-11.6%	$2.0B+43.4%	$1.4B
SG&A Expenses	$1.1B	$1.0B-10.4%	$1.2B+13.0%	$1.0B+3.5%	$997.8M+33.8%	$745.6M+5.8%	$704.5M-2.8%	$724.7M+13.3%	$639.8M+4.7%	$611.1M+1.6%	$601.3M-6.4%	$642.3M+6.6%	$602.6M+8.8%	$553.6M+11.1%	$498.2M+13.6%	$438.5M
Operating Income	$41.7M	$90.8M-84.5%	$584.4M-56.5%	$1.3B+19.0%	$1.1B+448.6%	$205.8M-25.8%	$277.3M-58.0%	$659.6M+45.8%	$452.4M+360.2%	-$173.9M-159.5%	$292.4M-59.1%	$715.4M-31.9%	$1.0B-14.3%	$1.2B-19.0%	$1.5B+56.9%	$964.3M
EBITDA	N/A	$742.2M-35.7%	$1.2B-38.7%	$1.9B+18.4%	$1.6B+138.4%	$667.5M-11.5%	$754.6M-33.4%	$1.1B+21.8%	$930.4M+203.7%	$306.3M-58.6%	$739.9M-30.9%	$1.1B-21.0%	$1.4B-9.7%	$1.5B-13.3%	$1.7B+46.2%	$1.2B
Interest Expense	$179.9M	$146.1M+40.4%	$104.1M-24.3%	$137.4M+20.4%	$114.2M+9.2%	$104.6M-10.6%	$117.0M-30.0%	$167.1M+12.0%	$149.2M-12.9%	$171.2M+50.6%	$113.7M+60.9%	$70.7M-16.8%	$84.9M-14.5%	$99.3M+5.5%	$94.1M+13.3%	$83.0M
Income Tax	-$6.3M	$16.8M+444.4%	-$4.9M-104.5%	$107.7M-18.5%	$132.1M+445.4%	-$38.2M-4.1%	-$36.7M-194.9%	-$12.5M+88.0%	-$104.1M+42.5%	-$181.1M-1048.3%	$19.1M+257.0%	-$12.2M-125.2%	$48.3M-46.1%	$89.7M+10.9%	$80.9M-6.7%	$86.6M
Net Income	$577.5M	$597.9M-45.8%	$1.1B-42.0%	$1.9B+13.2%	$1.7B+203.1%	$554.0M+31.1%	$422.4M-49.1%	$829.9M+7.0%	$775.9M+983.8%	$71.6M-81.3%	$383.2M-50.9%	$781.0M-27.8%	$1.1B+9.0%	$992.4M-21.3%	$1.3B+31.1%	$961.4M

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Revenue	$11.6B+18.6%	$8.4B+7.2%	$8.9B-4.6%	$8.6B-6.2%	$9.8B+1.6%	$7.8B-14.2%	$9.3B-18.4%	$9.2B-3.3%
Cost of Revenue	$11.2B+18.4%	$8.3B+7.9%	$8.5B-4.7%	$8.3B-7.0%	$9.4B+3.2%	$7.7B-11.5%	$8.9B-17.2%	$8.9B-1.7%
Gross Profit	$410.6M+24.5%	$25.8M-66.2%	$389.4M-2.8%	$330.0M+21.0%	$329.8M-29.5%	$76.3M-79.1%	$400.7M-37.9%	$272.7M-37.8%
SG&A Expenses	$302.3M+16.8%	$267.6M+7.8%	$268.1M+2.0%	$276.1M-8.0%	$258.9M-18.2%	$248.3M-16.8%	$262.9M+4.3%	$300.2M+6.1%
Operating Income	$108.3M+52.7%	-$241.8M-40.6%	$121.2M-12.0%	$53.9M+295.7%	$71.0M-53.1%	-$172.0M-354.1%	$137.8M-64.9%	-$27.6M-117.7%
EBITDA	$273.7M+18.8%	-$69.2M-308.7%	$292.1M+2.3%	$243.3M+101.7%	$230.3M-21.9%	-$16.9M-108.1%	$285.5M-46.2%	$120.6M-59.1%
Interest Expense	$49.7M+12.7%	$43.8M+73.6%	$37.4M+35.1%	$49.1M+92.2%	$44.1M+88.3%	$25.2M-1.0%	$27.6M-6.7%	$25.6M-18.3%
Income Tax	$14.7M-45.8%	-$17.8M-104.2%	$11.7M-11.4%	-$14.9M+43.2%	$27.2M+115.5%	-$8.7M-156.8%	$13.2M+303.1%	-$26.3M-163.6%
Net Income	$267.4M+15.2%	-$147.1M-94.1%	$260.5M+6.4%	$196.7M+75.9%	$232.2M-21.9%	-$75.8M-144.5%	$244.8M-53.2%	$111.8M-59.8%

Not reported in any period shown, so not listed: R&D Expenses, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).

CHSCN Balance Sheet

CHSCN quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$18.9B+0.8%	$18.7B-1.3%	$19.0B+0.7%	$18.8B+7.1%	$17.6B+9.9%	$16.0B-2.8%	$16.4B+0.4%	$16.4B+3.6%	$15.8B-8.6%	$17.3B+13.7%	$15.2B-0.4%	$15.3B+13.3%	$13.5B-1.0%	$13.6B+11.7%	$12.2B
Current Assets	$8.1B-7.1%	$8.7B-4.6%	$9.1B-2.7%	$9.4B+17.2%	$8.0B+27.6%	$6.3B-5.9%	$6.7B-0.5%	$6.7B+18.9%	$5.6B-18.8%	$6.9B-13.4%	$8.0B-14.8%	$9.4B+5.5%	$8.9B-7.8%	$9.7B+10.6%	$8.7B
Cash & Equivalents	$327.8M-58.8%	$794.9M-55.0%	$1.8B+122.3%	$794.0M+92.2%	$413.2M+193.3%	$140.9M-33.3%	$211.2M-53.1%	$450.6M+148.4%	$181.4M-37.5%	$290.3M-70.0%	$967.7M-54.6%	$2.1B+18.0%	$1.8B+475.9%	$314.0M-66.5%	$937.7M
Short-Term Investments	$0-100.0%	$500.9M	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$3.3B+6.6%	$3.1B-4.6%	$3.2B-12.0%	$3.7B+9.5%	$3.3B+21.6%	$2.7B-3.9%	$2.9B+3.1%	$2.8B+6.4%	$2.6B+9.7%	$2.4B-10.6%	$2.7B-3.9%	$2.8B+3.6%	$2.7B	N/A	N/A
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$239.4M+33.0%	$180.0M0.0%	$180.0M0.0%	$180.0M+4.9%	$171.6M-0.5%	$172.4M0.0%	$172.4M+24.5%	$138.5M0.0%	$138.5M-4.0%	$144.3M-3.9%	$150.1M-5.4%	$158.7M+86.6%	$85.1M+4.1%	$81.7M+209.3%	$26.4M
Total Liabilities	$7.8B-2.2%	$8.0B-6.5%	$8.5B-9.2%	$9.4B+9.4%	$8.6B+19.3%	$7.2B-8.3%	$7.8B-4.7%	$8.2B+1.2%	$8.1B-14.1%	$9.5B+25.0%	$7.6B-14.4%	$8.8B+5.7%	$8.4B-8.9%	$9.2B+18.4%	$7.8B
Current Liabilities	$5.3B-2.2%	$5.4B-8.4%	$5.9B-15.1%	$7.0B+9.9%	$6.3B+28.6%	$4.9B-11.9%	$5.6B-5.9%	$5.9B+8.2%	$5.5B-15.9%	$6.5B+24.0%	$5.3B-15.6%	$6.2B+7.7%	$5.8B-15.2%	$6.8B+14.4%	$6.0B
Non-Current Liabilities	$2.5B-2.1%	$2.6B-2.0%	$2.6B+8.0%	$2.4B+7.8%	$2.2B-1.0%	$2.3B+0.5%	$2.3B-1.6%	$2.3B-13.3%	$2.6B-10.1%	$2.9B+27.0%	$2.3B-11.6%	$2.6B+1.2%	$2.6B+9.1%	$2.4B+31.7%	$1.8B
Long-Term Debt	$1.7B-4.3%	$1.8B+0.2%	$1.8B+9.1%	$1.7B+5.6%	$1.6B-1.4%	$1.6B-8.5%	$1.7B-0.7%	$1.8B-12.9%	$2.0B-2.9%	$2.1B+65.2%	$1.3B-10.2%	$1.4B-3.2%	$1.5B+8.9%	$1.3B-5.6%	$1.4B
Total Equity	$11.1B+3.0%	$10.8B+2.9%	$10.4B+10.5%	$9.5B+5.0%	$9.0B+2.3%	$8.8B+2.3%	$8.6B+5.6%	$8.2B+6.0%	$7.7B-2.0%	$7.9B+2.5%	$7.7B+18.8%	$6.4B+25.7%	$5.1B+15.2%	$4.5B0.0%	$4.5B
Retained Earnings	$3.0B+7.5%	$2.8B+10.6%	$2.5B+23.4%	$2.1B+19.9%	$1.7B+5.9%	$1.6B+2.1%	$1.6B+6.9%	$1.5B+16.9%	$1.3B-19.9%	$1.6B+6.5%	$1.5B-7.1%	$1.6B+15.8%	$1.4B	N/A	N/A

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Total Assets	$20.8B+5.5%	$20.9B+4.0%	$20.7B+6.0%	$18.9B+0.8%	$19.7B+6.7%	$20.1B+4.9%	$19.6B-4.2%	$18.7B-1.3%
Current Assets	$9.9B+11.4%	$10.3B+5.8%	$9.9B+5.8%	$8.1B-7.1%	$8.9B+5.5%	$9.7B+4.0%	$9.4B-11.6%	$8.7B-4.6%
Cash & Equivalents	$497.6M+53.7%	$248.5M-42.7%	$374.7M-16.8%	$327.8M-58.8%	$323.9M+4.4%	$433.3M-31.6%	$450.5M-66.6%	$794.9M-55.0%
Short-Term Investments	$0	$0	$0-100.0%	$0-100.0%	$0	$0	$345.2M	$500.9M
Inventory	$3.6B+4.5%	$4.9B+5.2%	$4.3B+10.9%	$3.3B+6.6%	$3.5B+4.4%	$4.6B+18.1%	$3.9B-8.2%	$3.1B-4.6%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	N/A	N/A	N/A	$239.4M+33.0%	N/A	N/A	N/A	$180.0M0.0%
Total Liabilities	$9.6B+7.6%	$9.9B+4.9%	$9.5B+8.9%	$7.8B-2.2%	$8.9B+17.9%	$9.4B+11.8%	$8.8B-10.0%	$8.0B-6.5%
Current Liabilities	$6.8B+6.5%	$7.1B+4.4%	$7.0B+14.8%	$5.3B-2.2%	$6.4B+22.1%	$6.8B+14.8%	$6.1B-12.9%	$5.4B-8.4%
Non-Current Liabilities	$2.8B+10.3%	$2.8B+6.2%	$2.6B-4.5%	$2.5B-2.1%	$2.5B+8.6%	$2.6B+4.5%	$2.7B-2.9%	$2.6B-2.0%
Long-Term Debt	$2.0B+8.6%	$2.0B+8.5%	$1.7B-4.5%	$1.7B-4.3%	$1.8B+9.4%	$1.8B+9.4%	$1.8B+0.2%	$1.8B+0.2%
Total Equity	$11.2B+3.9%	$11.1B+3.2%	$11.2B+3.6%	$11.1B+3.0%	$10.8B-1.1%	$10.7B-0.5%	$10.8B+1.1%	$10.8B+2.9%
Retained Earnings	$3.2B+5.1%	$3.0B+5.3%	$3.2B+8.3%	$3.0B+7.5%	$3.0B-5.1%	$2.8B-4.8%	$2.9B+1.3%	$2.8B+10.6%

Not reported in any period shown, so not listed: Accounts Receivable.

CHSCN Cash Flow Statement

CHSCN quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$1.5B	$635.8M-50.1%	$1.3B-61.2%	$3.3B+68.7%	$1.9B+156.9%	$757.8M-30.3%	$1.1B-4.6%	$1.1B+6.1%	$1.1B+12.5%	$954.7M-24.3%	$1.3B+121.1%	$570.0M-60.5%	$1.4B-41.7%	$2.5B+244.1%	$718.6M+138.5%	$301.3M
Depreciation & Amortization	N/A	$651.4M+14.3%	$569.9M+5.6%	$539.5M+16.8%	$462.0M+0.1%	$461.7M-3.3%	$477.4M+0.9%	$473.2M-1.0%	$478.1M-0.5%	$480.2M+7.3%	$447.5M+25.9%	$355.4M+16.1%	$306.2M+10.7%	$276.6M+25.9%	$219.6M-0.5%	$220.7M
Capital Expenditures	$539.4M	$728.6M-9.9%	$808.8M+43.3%	$564.5M+59.3%	$354.4M+11.5%	$317.8M-24.0%	$418.4M-5.6%	$443.2M+24.7%	$355.4M-20.0%	$444.4M-35.9%	$692.8M-41.6%	$1.2B+29.1%	$919.1M+48.3%	$619.9M+32.3%	$468.6M+50.8%	$310.7M
Free Cash Flow	$932.9M	-$92.8M-120.0%	$464.1M-82.9%	$2.7B+70.8%	$1.6B+261.8%	$440.0M-34.2%	$668.9M-4.0%	$696.7M-3.1%	$719.1M+40.9%	$510.3M-10.1%	$567.8M+192.1%	-$616.8M-218.1%	$522.2M-71.8%	$1.9B+641.2%	$250.0M+2774.9%	-$9.3M
Investing Cash Flow	-$832.1M	-$880.6M+38.5%	-$1.4B-50.7%	-$950.2M-107.9%	-$457.1M-349.6%	-$101.7M+58.3%	-$243.7M+63.1%	-$661.3M-731.6%	-$79.5M+80.4%	-$405.0M+89.2%	-$3.7B-96.3%	-$1.9B-45.0%	-$1.3B-165.8%	-$495.3M+28.6%	-$694.2M-26.0%	-$551.0M
Financing Cash Flow	-$444.2M	-$230.6M+71.7%	-$814.3M+41.7%	-$1.4B-25.3%	-$1.1B-241.0%	-$326.6M+64.9%	-$931.1M-28.3%	-$725.6M+0.9%	-$732.2M-18.4%	-$618.3M-134.1%	$1.8B+1079.4%	$153.8M-23.6%	$201.4M+142.1%	-$478.0M+25.2%	-$638.9M-181.2%	$786.9M

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Operating Cash Flow	$1.1B+59.1%	-$569.0M+45.2%	-$337.8M-14.9%	$1.3B+14.2%	$696.6M+25.1%	-$1.0B-315.8%	-$294.0M-99.2%	$1.1B-15.3%
Depreciation & Amortization	$165.3M+3.7%	$172.6M+11.4%	$170.8M+15.7%	$189.3M+27.8%	$159.4M+11.1%	$155.0M+10.6%	$147.7M+7.0%	$148.2M+6.6%
Capital Expenditures	$123.3M-29.9%	$105.0M-36.4%	$116.0M-39.8%	$195.1M-27.0%	$175.9M-9.9%	$164.9M-19.0%	$192.7M+35.3%	$267.4M+40.5%
Free Cash Flow	$984.7M+89.1%	-$674.0M+44.0%	-$453.8M+6.7%	$1.1B+27.2%	$520.6M+44.0%	-$1.2B-165.4%	-$486.6M-67.8%	$845.8M-24.8%
Investing Cash Flow	-$298.4M+41.1%	$42.6M+208.6%	-$247.9M-3617.9%	-$328.4M+64.0%	-$506.3M-51.5%	-$39.2M+54.3%	-$6.7M+93.3%	-$912.1M-205.0%
Financing Cash Flow	-$525.2M-70.8%	$392.1M-63.3%	$644.2M+1887.4%	-$955.3M-439.6%	-$307.5M+43.6%	$1.1B+384.5%	-$36.0M+79.3%	$281.3M+213.3%

Not reported in any period shown, so not listed: Stock-Based Compensation, Dividends Paid, Share Buybacks.

CHSCN Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CHSCN quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	3.2%-1.3pp	4.5%-0.8pp	5.2%+0.8pp	4.5%+2.0pp	2.5%-1.0pp	3.5%-0.9pp	4.3%+1.0pp	3.3%+0.5pp	2.8%-0.4pp	3.2%-1.1pp	4.3%+0.4pp	3.9%-0.1pp	4.0%-1.0pp	5.0%+1.2pp	3.8%
Operating Margin	0.3%-1.2pp	1.5%-1.5pp	2.9%+0.6pp	2.4%+1.8pp	0.5%-0.4pp	1.0%-1.1pp	2.1%+0.7pp	1.4%+1.9pp	-0.5%-1.5pp	1.0%-1.1pp	2.1%-0.4pp	2.5%-0.3pp	2.8%-1.0pp	3.7%+1.1pp	2.6%
Net Margin	1.7%-1.1pp	2.8%-1.4pp	4.2%+0.7pp	3.5%+2.1pp	1.4%-0.1pp	1.5%-1.1pp	2.6%+0.2pp	2.4%+2.1pp	0.2%-1.0pp	1.3%-1.0pp	2.3%-0.3pp	2.5%+0.3pp	2.2%-0.9pp	3.1%+0.5pp	2.6%
Return on Equity	5.4%-4.8pp	10.3%-7.9pp	18.2%+0.4pp	17.8%+11.6pp	6.2%+1.3pp	4.8%-4.8pp	9.6%+0.1pp	9.5%+8.6pp	0.9%-4.0pp	4.9%-5.3pp	10.2%-6.6pp	16.8%-2.6pp	19.3%-8.9pp	28.3%+6.7pp	21.6%
Return on Assets	3.2%-2.7pp	5.9%-4.1pp	10.0%+1.1pp	8.9%+5.8pp	3.1%+0.5pp	2.6%-2.4pp	5.1%+0.3pp	4.7%+4.3pp	0.4%-1.8pp	2.2%-2.9pp	5.1%-1.9pp	7.1%-0.3pp	7.3%-1.9pp	9.2%+1.4pp	7.9%
Current Ratio	1.53-0.1x	1.61+0.1x	1.55+0.2x	1.35+0.1x	1.260.0x	1.27+0.1x	1.19+0.1x	1.13+0.1x	1.030.0x	1.06-0.5x	1.520.0x	1.510.0x	1.54+0.1x	1.420.0x	1.47
Debt-to-Equity	0.160.0x	0.170.0x	0.170.0x	0.180.0x	0.180.0x	0.180.0x	0.200.0x	0.220.0x	0.260.0x	0.27+0.1x	0.16-0.1x	0.22-0.1x	0.280.0x	0.300.0x	0.32
Asset Turnover	1.88-0.2x	2.10-0.3x	2.40-0.1x	2.54+0.4x	2.19+0.4x	1.78-0.2x	1.94-0.1x	2.000.0x	2.03+0.3x	1.75-0.5x	2.27-0.5x	2.79-0.5x	3.29+0.3x	2.980.0x	3.02
FCF Margin	-0.3%-1.4pp	1.2%-4.8pp	6.0%+2.6pp	3.3%+2.2pp	1.1%-1.2pp	2.4%+0.2pp	2.2%0.0pp	2.2%+0.6pp	1.6%-0.3pp	1.9%+3.7pp	-1.8%-3.0pp	1.2%-2.9pp	4.2%+3.6pp	0.6%+0.7pp	0.0%

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Gross Margin	3.5%+0.2pp	0.3%-0.7pp	4.4%+0.1pp	3.8%+0.9pp	3.4%-1.5pp	1.0%-3.1pp	4.3%-1.3pp	3.0%-1.6pp
Operating Margin	0.9%+0.2pp	-2.9%-0.7pp	1.4%-0.1pp	0.6%+0.9pp	0.7%-0.9pp	-2.2%-3.0pp	1.5%-2.0pp	-0.3%-1.9pp
Net Margin	2.3%-0.1pp	-1.8%-0.8pp	2.9%+0.3pp	2.3%+1.1pp	2.4%-0.7pp	-1.0%-2.8pp	2.6%-2.0pp	1.2%-1.7pp
Return on Equity	2.4%+0.2pp	-1.3%-0.6pp	2.3%+0.1pp	1.8%+0.7pp	2.1%-0.6pp	-0.7%-2.3pp	2.3%-2.6pp	1.0%-1.6pp
Return on Assets	1.3%+0.1pp	-0.7%-0.3pp	1.3%0.0pp	1.0%+0.4pp	1.2%-0.4pp	-0.4%-1.3pp	1.3%-1.3pp	0.6%-0.9pp
Current Ratio	1.47+0.1x	1.450.0x	1.42-0.1x	1.53-0.1x	1.40-0.2x	1.43-0.1x	1.540.0x	1.61+0.1x
Debt-to-Equity	0.180.0x	0.180.0x	0.160.0x	0.160.0x	0.170.0x	0.170.0x	0.170.0x	0.170.0x
Asset Turnover	0.56+0.1x	0.400.0x	0.430.0x	0.460.0x	0.500.0x	0.39-0.1x	0.47-0.1x	0.490.0x
FCF Margin	8.5%+3.2pp	-8.1%+7.4pp	-5.1%+0.1pp	12.5%+3.3pp	5.3%+1.6pp	-15.4%-10.4pp	-5.2%-2.7pp	9.2%-2.6pp

Where CHS Inc Preferred Ranks

Frequently Asked Questions

What is CHS Inc Preferred's annual revenue?

CHS Inc Preferred (CHSCN) reported $35.5B in total revenue for fiscal year 2025. This represents a -9.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is CHS Inc Preferred's revenue growing?

CHS Inc Preferred (CHSCN) revenue declined by 9.7% year-over-year, from $39.3B to $35.5B in fiscal year 2025.

Is CHS Inc Preferred profitable?

Yes, CHS Inc Preferred (CHSCN) reported a net income of $597.9M in fiscal year 2025, with a net profit margin of 1.7%.

What is CHS Inc Preferred's EBITDA?

CHS Inc Preferred (CHSCN) had EBITDA of $742.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does CHS Inc Preferred have?

As of fiscal year 2025, CHS Inc Preferred (CHSCN) had $327.8M in cash and equivalents against $1.7B in long-term debt.

What is CHS Inc Preferred's gross margin?

CHS Inc Preferred (CHSCN) had a gross margin of 3.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is CHS Inc Preferred's operating margin?

CHS Inc Preferred (CHSCN) had an operating margin of 0.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is CHS Inc Preferred's net profit margin?

CHS Inc Preferred (CHSCN) had a net profit margin of 1.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is CHS Inc Preferred's return on equity (ROE)?

CHS Inc Preferred (CHSCN) has a return on equity of 5.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is CHS Inc Preferred's free cash flow?

CHS Inc Preferred (CHSCN) recorded an outflow of $92.8M in free cash flow during fiscal year 2025. This represents a -120.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is CHS Inc Preferred's operating cash flow?

CHS Inc Preferred (CHSCN) generated $635.8M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are CHS Inc Preferred's total assets?

CHS Inc Preferred (CHSCN) had $18.9B in total assets as of fiscal year 2025, including both current and long-term assets.

What are CHS Inc Preferred's capital expenditures?

CHS Inc Preferred (CHSCN) invested $728.6M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How many shares does CHS Inc Preferred have outstanding?

CHS Inc Preferred (CHSCN) had 0 shares outstanding as of fiscal year 2025.

What is CHS Inc Preferred's current ratio?

CHS Inc Preferred (CHSCN) had a current ratio of 1.53 as of fiscal year 2025, which is generally considered healthy.

What is CHS Inc Preferred's debt-to-equity ratio?

CHS Inc Preferred (CHSCN) had a debt-to-equity ratio of 0.16 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is CHS Inc Preferred's return on assets (ROA)?

CHS Inc Preferred (CHSCN) had a return on assets of 3.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is CHS Inc Preferred's Piotroski F-Score?

CHS Inc Preferred (CHSCN) has a Piotroski F-Score of 4 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are CHS Inc Preferred's earnings high quality?

CHS Inc Preferred (CHSCN) has an earnings quality ratio of 1.06x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can CHS Inc Preferred cover its interest payments?

CHS Inc Preferred (CHSCN) has an interest coverage ratio of 0.62x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.